Happonen Kaisa E, Tran Sinh, Mörgelin Matthias, Prince Raja, Calzavarini Sara, Angelillo-Scherrer Anne, Dahlbäck Björn
From the Department of Translational Medicine, Division of Clinical Chemistry, Lund University, SE-20502 Malmö Sweden,
From the Department of Translational Medicine, Division of Clinical Chemistry, Lund University, SE-20502 Malmö Sweden.
J Biol Chem. 2016 May 13;291(20):10586-601. doi: 10.1074/jbc.M115.699058. Epub 2016 Mar 22.
Upon activation, platelets release plasma membrane-derived microparticles (PMPs) exposing phosphatidylserine on their surface. The functions and clearance mechanism of these microparticles are incompletely understood. As they are pro-coagulant and potentially pro-inflammatory, rapid clearance from the circulation is essential for prevention of thrombotic diseases. The tyrosine kinase receptors Tyro3, Axl, and Mer (TAMs) and their ligands protein S and Gas6 are involved in the uptake of phosphatidylserine-exposing apoptotic cells in macrophages and dendritic cells. Both TAMs and their ligands are expressed in the vasculature, the functional significance of which is poorly understood. In this study, we investigated how vascular TAMs and their ligands may mediate endothelial uptake of PMPs. PMPs, generated from purified human platelets, were isolated by ultracentrifugation and labeled with biotin or PKH67. The uptake of labeled microparticles in the presence of protein S and Gas6 in human aortic endothelial cells and human umbilical vein endothelial cells was monitored by flow cytometry, Western blotting, and confocal/electron microscopy. We found that both endothelial cell types can phagocytose PMPs, and by using TAM-blocking antibodies or siRNA knockdown of individual TAMs, we show that the uptake is mediated by endothelial Axl and Gas6. As circulating PMP levels were not altered in Gas6(-/-) mice compared with Gas6(+/+) mice, we hypothesize that the Gas6-mediated uptake is not a means to clear the bulk of circulating PMPs but may serve to locally phagocytose PMPs generated at sites of platelet activation and as a way to effect endothelial responses.
激活后,血小板会释放源自质膜的微粒(PMPs),这些微粒表面暴露有磷脂酰丝氨酸。这些微粒的功能和清除机制尚未完全明确。由于它们具有促凝血作用且可能具有促炎作用,因此从循环中快速清除对于预防血栓性疾病至关重要。酪氨酸激酶受体Tyro3、Axl和Mer(TAMs)及其配体蛋白S和Gas6参与巨噬细胞和树突状细胞对暴露磷脂酰丝氨酸的凋亡细胞的摄取。TAMs及其配体在脉管系统中均有表达,但其功能意义尚不清楚。在本研究中,我们探究了血管TAMs及其配体如何介导内皮细胞对PMPs的摄取。从纯化的人血小板产生的PMPs通过超速离心分离并用生物素或PKH67标记。通过流式细胞术、蛋白质印迹法以及共聚焦/电子显微镜监测人主动脉内皮细胞和人脐静脉内皮细胞在存在蛋白S和Gas6的情况下对标记微粒的摄取。我们发现这两种内皮细胞类型均可吞噬PMPs,并且通过使用TAM阻断抗体或对单个TAMs进行小干扰RNA敲低,我们表明摄取是由内皮细胞的Axl和Gas6介导的。由于与Gas6(+/+)小鼠相比,Gas6(-/-)小鼠循环中的PMP水平未发生改变,我们推测Gas6介导的摄取并非清除大部分循环中PMPs的方式,而是可能用于局部吞噬血小板激活部位产生的PMPs,并作为影响内皮细胞反应的一种方式。